Tg(CAG-cre/Esr1*)5Amc/?
Thratm1Ffla/Thra+
involves: 129/Sv * C57BL/6 * CBA
|
abnormal cerebellum morphology |
J:125353
|
|
abnormal heart rate |
J:125353
|
|
abnormal postnatal growth |
J:125353
|
|
delayed bone ossification |
J:125353
|
Tg(Nes-cre)1Kln/0
Thraem6Ffla/Thra+
involves: 129 * C57BL/6 * SJL
|
abnormal cerebellum morphology |
J:268664
|
|
postnatal lethality, incomplete penetrance |
J:268664
|
Tg(Nes-cre)1Kln/0
Thratm1Ffla/Thra+
involves: 129 * C57BL/6 * SJL
|
abnormal cerebellum morphology |
J:268664
|
|
postnatal lethality, incomplete penetrance |
J:268664
|
Thraem1Ffla/Thra+
C57BL/6-Thraem1Ffla
|
abnormal enterocyte proliferation |
J:268664
|
|
decreased hemoglobin content |
J:268664
|
|
decreased trabecular bone thickness |
J:268664
|
|
delayed endochondral bone ossification |
J:268664
|
|
normal
homeostasis/metabolism phenotype |
J:268664
|
|
increased triiodothyronine level |
J:268664
|
|
short femur |
J:268664
|
|
normal
skeleton phenotype |
J:268664
|
Thraem2Ffla/Thra+
C57BL/6-Thraem2Ffla
|
abnormal enterocyte proliferation |
J:268664
|
|
decreased hemoglobin content |
J:268664
|
|
decreased trabecular bone thickness |
J:268664
|
|
delayed endochondral bone ossification |
J:268664
|
|
increased triiodothyronine level |
J:268664
|
|
short femur |
J:268664
|
|
normal
skeleton phenotype |
J:268664
|
Thraem3Ffla/Thra+
C57BL/6-Thraem3Ffla
|
delayed endochondral bone ossification |
J:268664
|
|
normal
homeostasis/metabolism phenotype |
J:268664
|
|
normal
skeleton phenotype |
J:268664
|
Thraem4Ffla/Thra+
C57BL/6-Thraem4Ffla
|
delayed endochondral bone ossification |
J:268664
|
|
normal
homeostasis/metabolism phenotype |
J:268664
|
|
normal
skeleton phenotype |
J:268664
|
Thraem5Ffla/Thra+
C57BL/6-Thraem5Ffla
|
decreased trabecular bone thickness |
J:268664
|
|
normal
homeostasis/metabolism phenotype |
J:268664
|
|
normal
skeleton phenotype |
J:268664
|
Thratm1.1Fcas/Thratm1.1Fcas
B6.Cg-Thratm1.1Fcas
|
abnormal glucose homeostasis |
J:179839
|
|
abnormal insulin secretion |
J:179839
|
|
abnormal mitochondrial ATP synthesis coupled electron transport |
J:179839
|
|
abnormal pancreatic islet morphology |
J:179839
|
|
decreased body temperature |
J:179839
|
|
decreased food intake |
J:179839
|
|
impaired glucose tolerance |
J:179839
|
|
increased circulating glucagon level |
J:179839
|
|
increased circulating glucose level |
J:179839
|
|
increased circulating insulin level |
J:179839
|
|
increased circulating thyroxine level |
J:179839
|
|
increased circulating triiodothyronine level |
J:179839
|
|
increased glucagon secretion |
J:179839
|
|
increased insulin secretion |
J:179839
|
|
increased insulin sensitivity |
J:179839
|
|
insulin resistance |
J:179839
|
|
small pancreatic islets |
J:179839
|
Thratm1b(EUCOMM)Wtsi/Thra+
C57BL/6N-Thratm1b(EUCOMM)Wtsi/Ics
|
abnormal contextual conditioning behavior |
J:211773
|
|
abnormal heart left ventricle morphology |
J:211773
|
|
abnormal retina inner nuclear layer morphology |
J:211773
|
|
decreased body length |
J:211773
|
|
decreased exploration in new environment |
J:211773
|
|
decreased grip strength |
J:211773
|
|
decreased startle reflex |
J:211773
|
|
decreased total body fat amount |
J:211773
|
|
decreased total retina thickness |
J:211773
|
|
hyperactivity |
J:211773
|
|
improved glucose tolerance |
J:211773
|
|
increased blood urea nitrogen level |
J:211773
|
|
increased circulating alkaline phosphatase level |
J:211773
|
|
increased circulating creatinine level |
J:211773
|
|
increased hematocrit |
J:211773
|
|
increased vertical activity |
J:211773
|
|
limb grasping |
J:211773
|
|
short tibia |
J:211773
|
Thratm1b(EUCOMM)Wtsi/Thra+
C57BL/6N-Thratm1b(EUCOMM)Wtsi/J
|
abnormal bone structure |
J:211773
|
|
hyperactivity |
J:211773
|
|
increased bone mineral content |
J:211773
|
|
increased bone mineral density |
J:211773
|
|
increased startle reflex |
J:211773
|
Thratm1b(EUCOMM)Wtsi/Thratm1b(EUCOMM)Wtsi
C57BL/6N-Thratm1b(EUCOMM)Wtsi/Ics
|
preweaning lethality, incomplete penetrance |
J:211773
|
Thratm1b(EUCOMM)Wtsi/Thratm1b(EUCOMM)Wtsi
C57BL/6N-Thratm1b(EUCOMM)Wtsi/J
|
preweaning lethality, incomplete penetrance |
J:211773
|
Thratm1Brnt/Thra+
involves: 129S4/SvJae * C57BL/6
|
abnormal defecation |
J:85803
|
|
abnormal enzyme/coenzyme activity |
J:85803
|
|
decreased core body temperature |
J:85803
|
|
decreased food intake |
J:85803
|
|
decreased heart rate |
J:85803
|
|
delayed hair appearance |
J:85803
|
|
impaired adaptive thermogenesis |
J:85803
|
|
impaired lipolysis |
J:85803
|
|
increased body weight |
J:85803
|
|
increased circulating glucose level |
J:85803
|
|
increased circulating insulin level |
J:85803
|
|
increased circulating leptin level |
J:85803
|
|
increased circulating thyroid-stimulating hormone level |
J:85803
|
|
increased circulating thyroxine level |
J:85803
|
|
increased circulating triiodothyronine level |
J:85803
|
|
increased epididymal fat pad weight |
J:85803
|
|
increased total body fat amount |
J:85803
|
|
insulin resistance |
J:85803
|
|
oliguria |
J:85803
|
|
reduced fertility |
J:85803
|
Thratm1Brnt/Thratm1Brnt
involves: 129S4/SvJae * C57BL/6
|
prenatal lethality, complete penetrance |
J:85803
|
Thratm1Ffla/Thra+
Tg(Sycp1-cre)4Min/?
involves: 129/Sv * C57BL/6 * DBA/2
|
abnormal cerebellum external granule cell layer morphology |
J:125353
|
|
abnormal Purkinje cell dendrite morphology |
J:125353
|
|
ataxia |
J:125353
|
|
decreased spleen weight |
J:125353
|
|
delayed endochondral bone ossification |
J:125353
|
|
delayed eyelid opening |
J:125353
|
|
disproportionate dwarf |
J:125353
|
|
female infertility |
J:125353
|
|
impaired adaptive thermogenesis |
J:125353
|
|
increased heart rate |
J:125353
|
|
irregular heartbeat |
J:125353
|
|
postnatal growth retardation |
J:125353
|
|
postnatal lethality, incomplete penetrance |
J:125353
|
Thratm1Jas/Thratm1Jas
involves: 129S1/Sv * 129X1/SvJ
|
abnormal enterocyte morphology |
J:84537
|
|
abnormal enterocyte physiology |
J:84537
|
|
abnormal enterocyte proliferation |
J:84537
|
|
abnormal enzyme/coenzyme activity |
J:84537
|
|
abnormal intestinal goblet cell morphology |
J:84537
|
|
abnormal intestinal mucosa morphology |
J:84537
|
|
abnormal long bone epiphyseal plate morphology |
J:52829
|
|
abnormal small intestine morphology |
J:52829
|
|
abnormal thyroid follicle morphology |
J:52829
|
|
decreased circulating thyroxine level |
J:68577
|
|
decreased heart rate |
J:68577
|
|
decreased small intestinal villus height |
J:84537
|
|
decreased small intestine length |
J:52829
|
|
decreased ventricle muscle contractility |
J:68577
|
|
prolonged QRS complex duration |
J:68577
|
|
thyroid gland hypoplasia |
J:52829
|
Thratm1Ven/Thratm1Ven
involves: 129P2/OlaHsd * BALB/c
|
abnormal cochlear outer hair cell morphology |
J:111711
|
|
normal
behavior/neurological phenotype |
J:103702
|
|
decreased activity of thyroid gland |
J:45675
|
|
decreased body temperature |
J:45675
|
|
decreased heart rate |
J:45675
|
|
normal
hearing/vestibular/ear phenotype |
J:48666,
J:118178
|
|
prolonged QT interval |
J:45675
|
Thratm1Ven/Thratm3Ven
involves: 129P2/OlaHsd * C57BL/6NCrl
|
abnormal postnatal growth |
J:100290
|
|
decreased body weight |
J:100290
|
Thratm2Jas/Thratm2Jas
involves: 129
|
abnormal bone structure |
J:120899
|
|
abnormal chondrocyte physiology |
J:114970
|
|
abnormal enterocyte physiology |
J:84537
|
|
abnormal enterocyte proliferation |
J:84537
|
|
abnormal enzyme/coenzyme activity |
J:84537
|
|
abnormal intestinal goblet cell morphology |
J:84537
|
|
abnormal intestinal mucosa morphology |
J:84537
|
|
abnormal long bone epiphyseal plate morphology |
J:120899
|
|
abnormal osteoclast physiology |
J:120899
|
|
abnormal response/metabolism to endogenous compounds |
J:120899
|
|
abnormal trabecular bone morphology |
J:120899
|
|
decreased activity of thyroid gland |
J:120899
|
|
decreased body weight |
J:120899
|
|
decreased circulating insulin-like growth factor I level |
J:120899
|
|
decreased circulating thyroxine level |
J:68577,
J:120899
|
|
decreased compact bone thickness |
J:120899
|
|
decreased heart rate |
J:68577
|
|
decreased osteoclast cell number |
J:120899
|
|
decreased small intestinal villus height |
J:84537
|
|
decreased ventricle muscle contractility |
J:68577
|
|
decreased width of hypertrophic chondrocyte zone |
J:120899
|
|
delayed endochondral bone ossification |
J:120899
|
|
increased bone mass |
J:120899
|
|
increased long bone epiphyseal plate size |
J:120899
|
|
increased trabecular bone thickness |
J:120899
|
|
osteosclerosis |
J:120899
|
|
postnatal growth retardation |
J:120899
|
|
prolonged QRS complex duration |
J:68577
|
|
short limbs |
J:120899
|
|
short tail |
J:120899
|
|
short tibia |
J:120899
|
|
normal
skeleton phenotype |
J:120899
|
Thratm2Jas/Thratm2Jas
involves: 129/Sv * C57BL/6
|
decreased circulating thyroxine level |
J:126521
|
Thratm2Ven/Thra+
involves: 129P2/OlaHsd * BALB/c
|
abnormal compact bone morphology |
J:72959
|
|
abnormal thyroid gland physiology |
J:72959
|
|
abnormal thyroid-stimulating hormone level |
J:72959
|
|
abnormal trabecular bone morphology |
J:72959
|
|
decreased activity of thyroid gland |
J:72959
|
|
decreased body weight |
J:72959
|
|
decreased bone mineral density |
J:72959
|
|
decreased circulating insulin-like growth factor I level |
J:72959
|
|
decreased circulating thyroxine level |
J:72959
|
|
decreased circulating triiodothyronine level |
J:72959
|
|
decreased compact bone area |
J:72959
|
|
increased activity of thyroid gland |
J:72959
|
|
increased body temperature |
J:72959
|
|
increased heart rate |
J:72959
|
|
increased total body fat amount |
J:72959
|
|
obese |
J:72959
|
|
postnatal growth retardation |
J:72959
|
Thratm2Ven/Thratm2Ven
involves: 129P2/OlaHsd * BALB/c
|
abnormal compact bone morphology |
J:72959
|
|
abnormal osteoclast physiology |
J:72959
|
|
abnormal pup retrieval |
J:72959
|
|
abnormal thyroid follicle morphology |
J:72959
|
|
abnormal thyroid gland physiology |
J:72959
|
|
abnormal thyroid-stimulating hormone level |
J:72959
|
|
abnormal trabecular bone morphology |
J:72959
|
|
decreased activity of thyroid gland |
J:72959
|
|
decreased areal bone mineral density |
J:72959
|
|
decreased body weight |
J:72959
|
|
decreased bone mineral content |
J:72959
|
|
decreased circulating insulin-like growth factor I level |
J:72959
|
|
decreased circulating thyroxine level |
J:72959
|
|
decreased circulating triiodothyronine level |
J:72959
|
|
decreased compact bone area |
J:72959
|
|
increased activity of thyroid gland |
J:72959
|
|
increased body temperature |
J:72959
|
|
increased heart rate |
J:72959
|
|
increased total body fat amount |
J:72959
|
|
obese |
J:72959
|
|
perinatal lethality, incomplete penetrance |
J:72959
|
|
postnatal growth retardation |
J:72959
|
|
prolonged estrous cycle |
J:72959
|
|
reduced female fertility |
J:72959
|
Thratm2Ven/Thratm2Ven
involves: 129P2/OlaHsd * BALB/c * C57BL/6J
|
normal
hearing/vestibular/ear phenotype |
J:118402
|
Thratm2Ven/Thratm3Ven
involves: 129P2/OlaHsd * C57BL/6NCrl
|
decreased body weight |
J:100290
|
Thratm3Jas/Thratm3Jas
involves: 129
|
abnormal enterocyte physiology |
J:84537
|
|
abnormal enterocyte proliferation |
J:84537
|
|
abnormal enzyme/coenzyme activity |
J:84537
|
|
abnormal intestinal goblet cell morphology |
J:84537
|
Thratm3Ven/Thra+
involves: 129P2/OlaHsd * C57BL/6NCrl
|
abnormal cerebellum external granule cell layer morphology |
J:100910
|
|
abnormal hippocampus morphology |
J:100910
|
|
abnormal locomotor coordination |
J:100910
|
|
abnormal object recognition memory |
J:100910
|
|
abnormal postnatal growth |
J:100290
|
|
decreased body weight |
J:100290
|
|
increased anxiety-related response |
J:100910
|
Thratm3Ven/Thratm3Ven
involves: 129P2/OlaHsd * C57BL/6NCrl
|
decreased body weight |
J:100290
|
|
postnatal lethality, complete penetrance |
J:100290
|
Thratm4.1Ven/Thra+
involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrl * FVB/N
|
increased circulating triiodothyronine level |
J:166513
|
Thratm4.1Ven/Thratm4.1Ven
involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrl * FVB/N
|
decreased liver weight |
J:166513
|
Excel File
Analysis Tools